Table 1.
General characteristics of the COVID-19 International Collaborative Research Database
| Classification | Values | ||
|---|---|---|---|
|
| |||
| Total | Confirmed cases only | ||
| No. of claim (case) | 476 508 | 13 510 | |
|
| |||
| No. of patient (person) | 234 427 | 7590 | |
|
| |||
| Sex | Male | 111 947 | 3095 |
| Female | 122 480 | 4495 | |
|
| |||
| Age (y) | 0–9 | 8897 | 149 |
| 10–19 | 7428 | 346 | |
| 20–29 | 40 109 | 2844 | |
| 30–39 | 39 552 | 1432 | |
| 40–49 | 33 418 | 1795 | |
| 50–59 | 31 809 | 2673 | |
| 60–69 | 27 930 | 2178 | |
| 70–79 | 23 134 | 1229 | |
| 80–89 | 18 445 | 742 | |
| 90–99 | 3590 | 122 | |
| ≥100 | 116 | NA | |
|
| |||
| Top 5 diagnostic codes (%) | Special screening examination for other viral disease (44.3) | COVID-19 virus identified (72.5) | |
| Observation for other suspected diseases and conditions (6.0) | Special screening examination for other viral disease (14.5) | ||
| Fever, unspecified (4.0) | Contact with and exposure to other communicable diseases (1.7) | ||
| Contact with and exposure to other communicable diseases (4.0) | Isolation (1.5) | ||
| COVID-19 virus identified (3.7) | Coronavirus infection, unspecified site (1.2) | ||
|
| |||
| Top 5 healthcare services used (%) | Treatment | RT-PCR (2.7) | Inpatient medication preparation (1.8) |
| Safe hospital fee for infection prevention and control (management fee) (1.6) | RT-PCR (1.6) | ||
| Outpatient care – new patient (1.3) | General diet_dietitians (1.6) | ||
| Chest [X-ray] (1.2) | General diet_cook (1.5) | ||
| Full Picture Archiving and Communications System (1.0) | Chest [X-ray] (1.5) | ||
| Medical materials | Electrode & EKG (12.4) | Blood & solution for injection (20.9) | |
| Blood and solution for injection (10.4) | Electrode & EKG (20.3) | ||
| Fixed price items (9.2) | Continuous drainage (8.5) | ||
| Continuous drainage (8.8) | Genitourinary items (7.9) | ||
| Genitourinary items (7.3) | Endotracheal intubation (7.8) | ||
| Drugs | Sodium chloride (0.9) 0.9 g (9 mg/mL) (2.8) | Acetaminophen (encapsulated) (6.1) | |
| Acetaminophen (encapsulated) (2.5) | Lopinavir & ritonavir (4.2) | ||
| Sodium chloride (0.9) 9 g (9 mg/mL) (2.2) | Acetylcysteine (3.2) | ||
| Oxygen gas (1.9) | Ammonium chloride & chlorpheniramine maleate & dihydrocodeine tartrate & DL-methylephedrine hydrochloride (3.0) | ||
| Sodium chloride (0.9) 4.5 g (9 mg/mL) (1.7) | Hydrochloride sulfate (2.9) | ||
COVID-19, coronavirus disease 2019; NA, not applicable; RT-PCR, real time reverse transcription polymerase chain reaction; EKG, electrocardiogram.